SCHEMBL23745823

SCHEMBL23745823

Cc1cccc(C(CCNCCCN)c2cn(CC3CCCCC3)c3ccccc23)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 5/20 0.38
PADI4 Q9UM07 1/20 0.36
PDE4A P27815 3/20 0.35
PDE4B Q07343 3/20 0.35
PDE4C Q08493 3/20 0.35
PDE4D Q08499 3/20 0.35
CHRNB2 P17787 4/20 0.35
CHRNB4 P30926 4/20 0.35
CHRNA3 P32297 4/20 0.35
CHRNA4 P43681 4/20 0.35
GRIN1 Q05586 2/20 0.35
GRIN2A Q12879 2/20 0.35
GRM1 Q13255 2/20 0.35
TPSAB1 Q15661 1/20 0.35
ICMT O60725 1/20 0.35
MAPT P10636 1/20 0.35
ESRRA P11474 1/20 0.33
CAMK2D Q13557 1/20 0.33
DRD2 P14416 1/20 0.32
DRD4 P21917 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL23722097 0.99 CNR1 (0.38) CNR1PADI4PDE4APDE4BPDE4C
SCHEMBL23745874 0.92 ICMT (0.34) CNR1PADI4ICMTCAMK2D
Hydrochloric Acid SCHEMBL23721906 0.91 SLC6A4 (0.34) CNR1PADI4ICMTCAMK2D
SCHEMBL23745845 0.88 CNR1 (0.39) CNR1PADI4PDE4APDE4BPDE4C
SCHEMBL23721913 0.88 CNR1 (0.39) CNR1PADI4PDE4APDE4BPDE4C
SCHEMBL23745540 0.87 CNR2 (0.36) CNR1ICMTMAPTCNR2
SCHEMBL23722133 0.86 OPRM1 (0.35) CHRNB2CHRNB4CHRNA3CHRNA4GRIN1
SCHEMBL23745733 0.86 CNR1 (0.41) CNR1PADI4PDE4APDE4BPDE4C
Hydrochloric Acid SCHEMBL23722052 0.85 OPRM1 (0.36) CHRNB2CHRNB4CHRNA3CHRNA4GRIN1
Hydrochloric Acid SCHEMBL23722160 0.85 CNR1 (0.40) CNR1PADI4PDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210246115-A1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF BIOIMICS AB (SE) 2021-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210246115-A1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF FDPS, FPR1, F12 CNR1 1651/4885PADI4 1142/4885PDE4A 3715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.